Oral contraception: Patterns of non-compliance. The Coraliance study

European Journal of Contraception and Reproductive Health Care

Volumn 7, Issue 3, 2002, Pages 155-161

  Aubeny, E ^a   Buhler, M ^a   Colau, J C ^a   Vicaut, E ^a   Zadikian, M ^a   Childs, M ^a  

^a NONE   (France)

Author keywords

Compliance; Oral contraception; Women's behavior

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AMENORRHEA; ARTICLE; BLEEDING; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; CONSULTATION; CONTRACEPTION; DRUG HYPERSENSITIVITY; FEMALE; FIBROCYSTIC BREAST DISEASE; FRANCE; HEALTH BEHAVIOR; HUMAN; MENSTRUAL CYCLE; MIGRAINE; NORMAL HUMAN; OVARY DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SKIN DISEASE; UTERUS DISEASE; WEIGHT GAIN;

EID: 0036710001     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/ejc.7.3.155.161     Document Type: Article

References (18)

1. Oddens B, Guis F. L'observance et l'oubli de pilule en France en 1995. Contracept Fertil Sex 1996;24:290-6
2. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation. Contraception 1995;51: 283-8
3. Rosenberg M, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: A prospective evaluation. Fam Plann Perspect 1998;30: 89-92
4. Rosenberg M, Waugh MS. Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 1999;180:276-9
5. Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med 1995;40:355-60
6. Uzan M. Rapport sur la prévention et la prise en charge des grossesses des adolescentes. Ministère de l'emploi et de la solidarité; Novembre 1998. sante.gouv.fr
7. Hapangama DK, Glasier AF, Baird DT. Noncompliance among a group of women using a novel method of contraception. Fertil Steril 2001;76:1196-201
8. Childs M, Cayet J, Desnoyers E, Lagente JL. Les observatoires de la prise en charge du patient atteint d'une pathologie (ORP®) Vers l'établissement de nouveaux standards méthodologiques. Lett Pharmacol 1999;13:90-2
9. Clark LR. Will the pill make me sterile? Concerns and strategies to improve adherence to hormonal contraceptive regimens in adolescent girls. J Pediatr Adolesc Gynecol 2001;14:153-62
10. Hillard PJ. Oral contraception noncompliance: the extent of the problem. Adv Contracept 1992;8(Suppl 1): 13-20
11. Dardano KL, Burkman RT. Contraceptive compliance. Obstet Gynecol Clin North Am 2000;27:933-41
12. Guillebaud J. Advising women on which pill to take. Br Med J 1995;311:1111-12
13. Ruggiero RJ. Patient communication and counseling on contraception and hormone replacement therapy. Am J Manag Care 2001;7(Suppl 18):S580-5
14. Elomaa K, Rolland R, Brosens I, et al. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. Am J Obstet Gynecol 1998; 179:41-6
15. Spielmann D, the Gestodene Study Group 324. Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 μg/ethinylestradiol 15 μg and a 21-day regimen of desogestrel 150 μg/ethinylestradiol 20 μg. Eur J Contracept Reprod Health Care 1999;4(Suppl 2): 17-25
16. Korver T, Goorisen E, Guillebaud J. The combined oral contraceptive pill: What advice should we give when tablets are missed? Br J Obstet Gynaecol 1995; 102:601-7
17. Kubba A, Guillebaud J. Combined oral contraceptives: Acceptability and effective use. Br Med Bull 1993;49: 140-57
18. Mills AM, Wilkinson CL, Bromham DR, et al. Guidelines for prescribing combined oral contraceptives. Br Med J 1996;312:121-2